A prescription drug that surpasses $1 billion in sales is known as a blockbuster. It's a rare feat, but when a pharmaceutical company finds a true blockbuster drug the payoff is enormous. How enormous? Check out the three best-selling prescription drugs of all time.
Blockbuster Drug #1: Lipitor
Company: Pfizer (PFE (opens in new tab))
Treats: High cholesterol
Sign up for Kiplinger’s Free E-Newsletters
Profit and prosper with the best of Kiplinger’s expert advice on investing, taxes, retirement, personal finance and more - straight to your e-mail.
Profit and prosper with the best of Kiplinger’s expert advice - straight to your e-mail.
Lifetime sales: $150.1 billion
Originally developed by Warner-Lambert, Lipitor was approved in the U.S. in 1997. Pfizer acquired its rival in 2000 to gain sole ownership of the cholesterol-fighting drug – and it was well worth it. At one point, Lipitor accounted for one-fourth of Pfizer’s sales. The patent expired in 2011.
Blockbuster Drug #2: Humira
Company: AbbVie (ABBV (opens in new tab))
Treats: Ankylosing spondylitis, arthritis, Crohn’s disease, plaque psoriasis, ulcerative colitis
Lifetime sales: $109.2 billion
Doctors praise Humira’s ability to combat damaging inflammation caused by a number of diseases. Sales will likely peak in 2018 as the drug begins to lose patent protection, but it’s been a heck of a run. Humira is owned by AbbVie, an industry giant that was spun off from Abbott Labs in 2013.
Blockbuster Drug #3: Advair
Company: GlaxoSmithKline (GSK (opens in new tab))
Treats: Chronic obstructive pulmonary disease, asthma
Lifetime sales: $95.7 billion
Advair has been a huge seller since its approval in 2001. And even though its U.S. patent expired in 2010, no successful generic competitor has surfaced. Copying the drug isn’t the problem. Rather, rivals have yet to figure out how to copy the inhaler. Until they do, Glaxo investors can breathe easy.
-
-
State "Stimulus Checks" Are a Thing in 2022 – Will You Get One?
To help counter high inflation, pandemic woes and other financial hardships, some states are sending tax rebate "stimulus" checks or other payments to residents.
-
How Young People Can Own Their Financial Future Authentically
It starts with trusting the process. The good news is Gen Zers and younger Millennials are on their way, a new study says.
-
How Big Should My Emergency Fund Be?
Brandon Copeland NFL linebacker and Kiplinger contributing editor Brandon Copeland discusses the importance of building an emergency fund.
-
Homeowners Insurance: How to Protect Your Home
Brandon Copeland NFL linebacker and Kiplinger contributing editor Brandon Copeland discusses the ins and outs of homeowners insurance.
-
The 10 Best Stocks for a Bear Market
stocks to buy The ideal bear-market stock pick should have a defensive business, a long history of dividend growth and relatively low volatility. Here are 10 stocks that fit that bill.
-
15 Stocks Warren Buffett Is Buying (And 7 He's Selling)
stocks Berkshire Hathaway CEO Warren Buffett is a bull once more! The Oracle and his team entered eight new positions and added to others in a big way.
-
The "Real" Cost of Buying a Car
Brandon Copeland Atlanta Falcons linebacker and Kiplinger contributing editor Brandon Copeland illustrates how car prices are far more than meets the eye.
-
How to Plan a Budget-Friendly Family Vacation
Brandon Copeland Atlanta Falcons linebacker and Kiplinger contributing editor Brandon Copeland provides tips on how to go on vacation without breaking the bank.
-
The Great Resignation: How to Quit Your Job With Confidence
Brandon Copeland Atlanta Falcons linebacker and Kiplinger contributing editor Brandon Copeland provides tips on how to properly quit your job and upgrade your career.
-
How to Achieve Your 2022 New Year's Resolutions
Brandon Copeland You've already made your New Year's resolutions. Atlanta Falcons linebacker and Kiplinger contributing editor Brandon Copeland explains how you can stick with them and accomplish them.
